Alma Bio Therapeutics
  • Home
  • About Us
    • About Us
    • The People
  • Our Approach
    • Autoimmune Diseases
    • Our Therapeutic Approach
  • Pipeline
  • News
  • Contact Us

Author: Agnes

This author has written 10 articles

Drug Mechanism of Action demonstrated: Mucosal healing without immune suppression

  • Agnes
  • April 26, 2022
  • News

April 2022 - A major study elucidating the mechanism of action of the IBD-asset has been completed: Alma's treatment facilitates mucosal healing without immune suppression

Continue Reading

New PCT: Nucleic acid therapy for differential modulation of host microflora

  • Agnes
  • April 26, 2022
  • News

March 2022 - WO 2022/070052 A1, a new PCT covering the effect of our IBD-asset on gut dysbiosis and impaired barrier function, was published online.

Continue Reading

ECCO 2022

  • Agnes
  • April 26, 2022
  • News

February 2022 - Alma attended ECCO 2022, the 17th congress of European Crohn's and Colitis Organisation

Continue Reading

CCFI /Région Auvergne Rhône-Alpes

  • Agnes
  • April 13, 2021
  • News

March 2021 - Alma Bio Therapeutics presented in the biotech session of the special webinar “Bouncing back from the crisis. How to re-establish partnerships between Israel and the Auvergne Rhône-Alpes…

Continue Reading

4th Antigen Specific Immune Tolerance event

  • Agnes
  • April 13, 2021
  • News

January 2021 – Alma Bio Therapeutics attended the 4th Antigen Specific Immune Tolerance digital event.

Continue Reading

Prof. Francisco Javier Quintana joins Alma’s scientific advisory board

  • Agnes
  • April 13, 2021
  • News Archive

September 2020 - Prof. Francisco Javier Quintana of Brigham and Women’s Hospital Harvard Medical School, a world-renowned expert in immune regulation and tolerance, joins Alma’s scientific advisory board.

Continue Reading

French PGE

  • Agnes
  • April 13, 2021
  • News Archive

July 2020 - Alma Bio Therapeutics was among the recipients of PGE, the French government state guaranteed loan.

Continue Reading

BioEurope Spring

  • Agnes
  • April 13, 2021
  • News Archive

March 2020 - Alma Bio Therapeutics participated at Digital BioEurope Spring

Continue Reading

RESI Partnering Event

  • Agnes
  • April 13, 2021
  • News Archive

March 2020 - Alma Bio Theraeutics presented at the RESI Digital partnering event

Continue Reading

Health Investor Day

  • Agnes
  • September 4, 2019
  • News Archive
  • 0 Comments

Dr Binah Baum, Alma Bio Therapeutics CEO, was at the Health Investor Day in Paris on June 24th-25th, 2019.

Continue Reading

Recent Posts

  • Drug Mechanism of Action demonstrated: Mucosal healing without immune suppression
  • New PCT: Nucleic acid therapy for differential modulation of host microflora
  • ECCO 2022
  • CCFI /Région Auvergne Rhône-Alpes
  • 4th Antigen Specific Immune Tolerance event

Questions? Contact Us!

Site Navigation

  • Home
  • About Us
  • Our Approach
  • Pipeline
  • News
  • Legal Notice

Contact Info

  • ALMA BIO THERAPEUTICS
  • HQ Lyon Vaise Business Center
    3, place Giovanni Da Verrazzano
    Lyon 69009 France
  • +33 4 37 66 47 49
  • message@alma-bio.com
© All Right Reserved to Alma Bio Therapeutics 2018